BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - Hedge Fund Holdings

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.15 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BDRX stock?

Hedge funds tracked by Rallies that own BDRX include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biodexa Pharmaceuticals plc American Depositary Shs.

BDRX Key Metrics

Key financial metrics for BDRX
MetricValue
Price$3.15
Market Cap$2.04M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$544.50
52-Week Low$2.86
Volume610
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Top Hedge Funds Holding BDRX

  • Two Sigma holds 32.58K shares of BDRX, changed +58.47% as of Sep 30, 2024.

Latest BDRX News

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Common questions about BDRX

Who owns BDRX stock?
Hedge funds tracked by Rallies that own BDRX include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biodexa Pharmaceuticals plc American Depositary Shs.
Does Rallies show 13F holders for BDRX?
Yes. Rallies tracks hedge fund and 13F ownership data for BDRX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BDRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.
BDRX

BDRX